1 |
An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021)
Shin-Wha Lee, Yong-Man Kim, Chi Heum Cho, Young Tae Kim, Seok Mo Kim, Soo Young Hur, Jae-Hoon Kim, Byoung-Gie Kim, Seung-Cheol Kim, Hee-Sug Ryu, Soon Beom Kang
Cancer Res Treat.2018;50(1):195-203. Published online 2017 March 21
DOI: http://dx.doi.org/10.4143/crt.2016.376
|
3 |
An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer
In Hae Park, Joo Hyuk Sohn, Sung Bae Kim, Keun Seok Lee, Joo Seop Chung, Soo Hyeon Lee, Tae You Kim, Kyung Hae Jung, Eun Kyung Cho, Yang Soo Kim, Hong Suk Song, Jae Hong Seo, Hun Mo Ryoo, Sun Ah Lee, So Young Yoon, Chul Soo Kim, Yong Tai Kim, Si Young Kim, Mi Ryung Jin, Jungsil Ro
Cancer Res Treat.2017;49(3):569-577. Published online 2016 September 12
DOI: http://dx.doi.org/10.4143/crt.2016.289
|
4 |
A Case of Ischemic Colitis Associated with Paclitaxel Loaded Polymeric Micelle (Genexol-PM®) Chemotherapy
Choel-Kyu Park, Hyun-Wook Kang, Tae-Ok Kim, Ho-Seok Ki, Eun-Young Kim, Hee-Jung Ban, Byeong-Kab Yoon, In-Jae Oh, Yoo-Deok Choi, Yong-Soo Kwon, Yoo-Il Kim, Sung-Chul Lim, Young-Chul Kim, Kyu-Sik Kim
|